BiotechTube

Placebo + YH14618

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Disc Degenerative Disease

Conditions

Disc Degenerative Disease

Trial Timeline

Mar 1, 2015 → Aug 1, 2016

NCT ID
NCT02320019

About Placebo + YH14618

Placebo + YH14618 is a phase 2 stage product being developed by Yuhan for Disc Degenerative Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT02320019. Target conditions include Disc Degenerative Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02320019Phase 2Completed

Competing Products

20 competing products in Disc Degenerative Disease

See all competitors
ProductCompanyStageHype Score
YH14618 + YH14618 + YH14618 + PlaceboYuhanPhase 1/2
41
SecukinumabNovartisPhase 2
52
Placebo + DaxdilimabAmgenPhase 2
51
Tofacitinib citratePfizerPhase 1
32
EtanerceptPfizerPhase 2
51
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
51
Belimumab 1 mg/kg + Belimumab 10 mg/kgGSK plcPre-clinical
22
RuxolitinibIncytePhase 2
49
Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuseMesoblastPhase 2
47
NeoFuseMesoblastPhase 2
47
Rexlemestrocel-L + HA mixture + SalineMesoblastPhase 3
72
Single Dose MPCs Injection + Single Dose MPCs InjectionMesoblastPhase 2
47
Rexlemestrocel-L + Rexlemestrocel-L + HA Mixture + PlaceboMesoblastPhase 3
72
NeoFuseMesoblastPhase 1/2
36
NeoFuseMesoblastPhase 1/2
36
PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuseMesoblastPhase 1/2
36
Processed Nerve Allograft (human)AxogenPhase 3
72
R932333 + PlaceboRigel PharmaceuticalsPhase 2
44
3,4-methylenedioxymethamphetamine or PlaceboPacific BiosciencesPre-clinical
15
Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCsBrain BiotechPhase 2/3
57

Other Products from Yuhan

generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85